The MTNR1b rs10830962 and rs10830963 polymorphisms have been predominantly investigated in the context of metabolic disorders, of which rs10830962 and rs10830963 G alleles were reported to associate with reduced insulin secretion, increased fasting plasma glucose concentrations, and increased risk for diabetes in different populations [42–44]. This evidence concerns the gene MTNR1B and Other metabolic disease.